Twelve or 30 Months of Dual Antiplatelet Therapy After Drug-eluting Stents

BACKGROUND: Dual antiplatelet therapy is recommended after coronary stenting to prevent thrombotic complications, yet the benefits and risks of treatment beyond 1 year are uncertain. METHODS: Subjects were enrolled after a drug-eluting coronary stent procedure. After 12 months of thienopyridine (clo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:N Engl J Med
Autors principals: Mauri, Laura, Kereiakes, Dean J., Yeh, Robert W., Driscoll-Shempp, Priscilla, Cutlip, Donald E., Steg, P. Gabriel, Normand, Sharon-Lise T., Braunwald, Eugene, Wiviott, Stephen D., Cohen, David J., Holmes, David R., Krucoff, Mitchell W., Hermiller, James, Dauerman, Harold L., Simon, Daniel I., Kandzari, David E., Garratt, Kirk N., Lee, David P., Pow, Thomas K., Lee, Peter Ver, Rinaldi, Michael J., Massaro, Joseph M.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4481318/
https://ncbi.nlm.nih.gov/pubmed/25399658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1409312
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars